Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ironwood Pharmaceuticals (IRWD) Accumulated Depreciation & Amortization (2016 - 2025)

Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization history spans 16 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 8.33% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, down 8.33%, while the annual FY2025 figure was $1.1 million, 8.33% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $1.1 million at Ironwood Pharmaceuticals, down from $1.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.5 million in Q4 2021 and bottomed at $1.1 million in Q4 2025.
  • The 5-year median for Accumulated Depreciation & Amortization is $1.2 million (2023), against an average of $1.3 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization crashed 34.78% in 2021 before it changed 0.0% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.5 million in 2021, then decreased by 6.67% to $1.4 million in 2022, then dropped by 14.29% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then decreased by 8.33% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Accumulated Depreciation & Amortization are $1.1 million (Q4 2025), $1.2 million (Q4 2024), and $1.2 million (Q4 2023).